De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Jardine Cycle & Carriage Toekomstige groei
Future criteriumcontroles 0/6
Jardine Cycle & Carriage zal naar verwachting groeien in winst en omzet met respectievelijk 1.6% en 2.8% per jaar. De winst per aandeel zal naar verwachting groeien met 3.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.3% zijn.
Belangrijke informatie
1.6%
Groei van de winst
3.8%
Groei van de winst per aandeel
| Industrials winstgroei | 14.1% |
| Inkomstengroei | 2.8% |
| Toekomstig rendement op eigen vermogen | 12.3% |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 04 Sep 2024 |
Recente toekomstige groei-updates
Recent updates
The Returns At Jardine Cycle & Carriage (SGX:C07) Aren't Growing
Sep 07
Jardine Cycle & Carriage (SGX:C07) Seems To Use Debt Quite Sensibly
Jun 24A Look At The Intrinsic Value Of Jardine Cycle & Carriage Limited (SGX:C07)
May 23Returns Are Gaining Momentum At Jardine Cycle & Carriage (SGX:C07)
May 07Most Shareholders Will Probably Agree With Jardine Cycle & Carriage Limited's (SGX:C07) CEO Compensation
Apr 22The Returns At Jardine Cycle & Carriage (SGX:C07) Aren't Growing
Jan 19Jardine Cycle & Carriage Limited (SGX:C07) Could Be Riskier Than It Looks
Dec 27Jardine Cycle & Carriage (SGX:C07) Has A Pretty Healthy Balance Sheet
Oct 31Estimating The Intrinsic Value Of Jardine Cycle & Carriage Limited (SGX:C07)
Oct 09Returns At Jardine Cycle & Carriage (SGX:C07) Appear To Be Weighed Down
Sep 21Jardine Cycle & Carriage Limited's (SGX:C07) Intrinsic Value Is Potentially 24% Below Its Share Price
Jul 08Is Jardine Cycle & Carriage (SGX:C07) Using Too Much Debt?
Jun 16The Returns At Jardine Cycle & Carriage (SGX:C07) Aren't Growing
May 29Does Jardine Cycle & Carriage (SGX:C07) Have A Healthy Balance Sheet?
Mar 16Calculating The Intrinsic Value Of Jardine Cycle & Carriage Limited (SGX:C07)
Feb 27Jardine Cycle & Carriage's (SGX:C07) Returns Have Hit A Wall
Jan 23An Intrinsic Calculation For Jardine Cycle & Carriage Limited (SGX:C07) Suggests It's 32% Undervalued
Nov 12Here's What To Make Of Jardine Cycle & Carriage's (SGX:C07) Decelerating Rates Of Return
Oct 25Jardine Cycle & Carriage (SGX:C07) Has A Rock Solid Balance Sheet
Oct 04Some Investors May Be Worried About Jardine Cycle & Carriage's (SGX:C07) Returns On Capital
Jul 19Jardine Cycle & Carriage (SGX:C07) Seems To Use Debt Quite Sensibly
Jun 22There Are Reasons To Feel Uneasy About Jardine Cycle & Carriage's (SGX:C07) Returns On Capital
Apr 01Here's Why Jardine Cycle & Carriage (SGX:C07) Can Manage Its Debt Responsibly
Mar 17When Should You Buy Jardine Cycle & Carriage Limited (SGX:C07)?
Jan 05Returns On Capital At Jardine Cycle & Carriage (SGX:C07) Have Hit The Brakes
Dec 18These 4 Measures Indicate That Jardine Cycle & Carriage (SGX:C07) Is Using Debt Reasonably Well
Nov 03An Intrinsic Calculation For Jardine Cycle & Carriage Limited (SGX:C07) Suggests It's 25% Undervalued
Oct 13When Should You Buy Jardine Cycle & Carriage Limited (SGX:C07)?
Sep 28Returns On Capital At Jardine Cycle & Carriage (SGX:C07) Have Stalled
Sep 09Jardine Cycle & Carriage's (SGX:C07) Soft Earnings Don't Show The Whole Picture
Aug 05Here's Why Jardine Cycle & Carriage (SGX:C07) Can Manage Its Debt Responsibly
Jul 30Are Investors Undervaluing Jardine Cycle & Carriage Limited (SGX:C07) By 21%?
Jun 25Investors Met With Slowing Returns on Capital At Jardine Cycle & Carriage (SGX:C07)
Jun 11These 4 Measures Indicate That Jardine Cycle & Carriage (SGX:C07) Is Using Debt Extensively
Mar 01Is It Time To Consider Buying Jardine Cycle & Carriage Limited (SGX:C07)?
Feb 15
Reflecting on Jardine Cycle & Carriage's (SGX:C07) Share Price Returns Over The Last Three Years
Jan 23Is Jardine Cycle & Carriage Limited (SGX:C07) Worth S$19.9 Based On Its Intrinsic Value?
Jan 05Here's What To Make Of Jardine Cycle & Carriage's (SGX:C07) Returns On Capital
Dec 21Key Things To Watch Out For If You Are After Jardine Cycle & Carriage Limited's (SGX:C07) 5.7% Dividend
Dec 06Has Jardine Cycle & Carriage Limited's (SGX:C07) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Nov 20Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 22,800 | 1,095 | 738 | 2,019 | 4 |
| 12/31/2025 | 22,237 | 1,009 | 846 | 2,014 | 5 |
| 12/31/2024 | 21,359 | 974 | 1,155 | 2,239 | 5 |
| 6/30/2024 | 21,362 | 1,050 | 1,512 | 2,789 | N/A |
| 3/31/2024 | 21,798 | 1,133 | 1,225 | 2,630 | N/A |
| 12/31/2023 | 22,235 | 1,215 | 938 | 2,471 | N/A |
| 9/30/2023 | 22,302 | 1,058 | 1,271 | 2,693 | N/A |
| 6/30/2023 | 22,470 | 901 | 1,604 | 2,915 | N/A |
| 3/31/2023 | 22,018 | 820 | 1,786 | 2,883 | N/A |
| 12/31/2022 | 21,566 | 740 | 1,967 | 2,851 | N/A |
| 9/30/2022 | 20,824 | 831 | 2,260 | 3,034 | N/A |
| 6/30/2022 | 20,082 | 922 | 2,552 | 3,218 | N/A |
| 3/31/2022 | 18,885 | 791 | 2,541 | 3,123 | N/A |
| 12/31/2021 | 17,688 | 661 | 2,529 | 3,028 | N/A |
| 9/30/2021 | 16,307 | 563 | 2,765 | 3,217 | N/A |
| 6/30/2021 | 14,927 | 466 | 3,001 | 3,405 | N/A |
| 3/31/2021 | 14,080 | 503 | 2,657 | 3,080 | N/A |
| 12/31/2020 | 13,234 | 540 | 2,314 | 2,754 | N/A |
| 9/30/2020 | 14,597 | 573 | 1,583 | 2,146 | N/A |
| 6/30/2020 | 16,029 | 755 | 1,236 | 1,920 | N/A |
| 3/31/2020 | 17,172 | 719 | 953 | 1,764 | N/A |
| 12/31/2019 | 18,591 | 881 | 677 | 1,712 | N/A |
| 9/30/2019 | 18,917 | 773 | 1,202 | 2,287 | N/A |
| 6/30/2019 | 18,960 | 672 | 1,499 | 2,648 | N/A |
| 3/31/2019 | 19,065 | 597 | 856 | 1,978 | N/A |
| 12/31/2018 | 18,992 | 418 | 1,560 | 2,614 | N/A |
| 9/30/2018 | 18,593 | 708 | 1,140 | 2,196 | N/A |
| 6/30/2018 | 18,172 | 713 | 509 | 1,454 | N/A |
| 3/31/2018 | 17,831 | 862 | N/A | 1,746 | N/A |
| 12/31/2017 | 17,337 | 939 | N/A | 1,655 | N/A |
| 9/30/2017 | 16,859 | 793 | N/A | 1,413 | N/A |
| 6/30/2017 | 16,414 | 773 | N/A | 1,621 | N/A |
| 3/31/2017 | 16,264 | 773 | N/A | 1,335 | N/A |
| 12/31/2016 | 15,764 | 702 | N/A | 1,417 | N/A |
| 9/30/2016 | 15,414 | 665 | N/A | 1,527 | N/A |
| 6/30/2016 | 15,184 | 659 | N/A | 1,599 | N/A |
| 3/31/2016 | 15,348 | 655 | N/A | 1,599 | N/A |
| 12/31/2015 | 15,718 | 691 | N/A | 1,848 | N/A |
| 9/30/2015 | 16,499 | 714 | N/A | 1,805 | N/A |
| 6/30/2015 | 17,410 | 746 | N/A | 1,516 | N/A |
| 3/31/2015 | 18,023 | 779 | N/A | 1,669 | N/A |
| 12/31/2014 | 18,675 | 820 | N/A | 1,240 | N/A |
| 9/30/2014 | 18,854 | 887 | N/A | 1,227 | N/A |
| 6/30/2014 | 18,887 | 896 | N/A | 1,599 | N/A |
| 3/31/2014 | 19,247 | 902 | N/A | 1,530 | N/A |
| 12/31/2013 | 19,788 | 915 | N/A | 1,931 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei van C07 ( 1.6% per jaar) ligt onder de spaarquote ( 2.2% ).
Winst versus markt: De winst van C07 ( 1.6% per jaar) zal naar verwachting langzamer groeien dan de markt SG ( 10.1% per jaar).
Hoge groeiwinsten: De winst van C07 zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van C07 ( 2.8% per jaar) zal naar verwachting langzamer groeien dan de markt SG ( 3.6% per jaar).
Hoge groei-inkomsten: De omzet van C07 ( 2.8% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen C07 zal naar verwachting over 3 jaar laag zijn ( 12.3 %).